DERIVATIVES OF 2-AMINOPYRIDINE AS ADENOSINE A2B RECEPTOR ANTAGONISTS AND LIGANDS OF THE MELATONIN MT3 RECEPTORS

as A2B adenosine receptor antagonists and ligands of MT3 melatonin receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by...

Full description

Saved in:
Bibliographic Details
Main Authors Camacho Gómez, Juan Alberto, Castro-Palomino Laria, Julio Cesar, Mendoza Lizaldez, Adela
Format Patent
LanguageCroatian
English
Published 20.03.2020
Subjects
Online AccessGet full text

Cover

Loading…
Abstract as A2B adenosine receptor antagonists and ligands of MT3 melatonin receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by antagonizing the adenosine A2B receptor and by inhibition of MT3 melatonin receptor, such as respiratory disease, metabolic disorders, neurological disorders and cancer.
AbstractList as A2B adenosine receptor antagonists and ligands of MT3 melatonin receptor, to processes for their preparation, to pharmaceutical compositions comprising said compounds and to the use of said for manufacturing a medicament for the treatment of pathological conditions or diseases that can improve by antagonizing the adenosine A2B receptor and by inhibition of MT3 melatonin receptor, such as respiratory disease, metabolic disorders, neurological disorders and cancer.
Author Castro-Palomino Laria, Julio Cesar
Camacho Gómez, Juan Alberto
Mendoza Lizaldez, Adela
Author_xml – fullname: Camacho Gómez, Juan Alberto
– fullname: Castro-Palomino Laria, Julio Cesar
– fullname: Mendoza Lizaldez, Adela
BookMark eNqNjM0KgzAQhHNoD_17h4WehTT1BVKzakA3kixCTyIlPRUV7PtTkdJzTx_DfDN7sRnGIe7EaNDbVrNtMYDLQSW6tuSau7fGEoIOoA2SC2tQN_CYYcPOgybWhSMbeFHIQGWLBesJlwg1VpqXmqDm628VjmL77F9zPH15EOccOSuTOI1dnKf-EYf47krfKKmklGnKfLn-Z30AwTs6Tw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate DERIVATI 2-AMINOPIRIDINA KAO ANTAGONISTI ADENOZINSKOG RECEPTORA A2B I LIGANDI MELATONINSKIH RECEPTORA MT3
ExternalDocumentID HRP20200044TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20200044TT13
IEDL.DBID EVB
IngestDate Fri Jul 19 13:13:33 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20200044TT13
Notes Application Number: HR2020P000044T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200320&DB=EPODOC&CC=HR&NR=P20200044T1
ParticipantIDs epo_espacenet_HRP20200044TT1
PublicationCentury 2000
PublicationDate 20200320
PublicationDateYYYYMMDD 2020-03-20
PublicationDate_xml – month: 03
  year: 2020
  text: 20200320
  day: 20
PublicationDecade 2020
PublicationYear 2020
RelatedCompanies Palobiofarma, S.L
RelatedCompanies_xml – name: Palobiofarma, S.L
Score 3.2548394
Snippet as A2B adenosine receptor antagonists and ligands of MT3 melatonin receptor, to processes for their preparation, to pharmaceutical compositions comprising said...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title DERIVATIVES OF 2-AMINOPYRIDINE AS ADENOSINE A2B RECEPTOR ANTAGONISTS AND LIGANDS OF THE MELATONIN MT3 RECEPTORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200320&DB=EPODOC&locale=&CC=HR&NR=P20200044T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivqmU_FjSkDpW3Fts849FOmadK2saWnjmE-ytAVF2MZW8d_3Gvbh057yccmRHPySXO5yQehRFpZRwMKvw9m10Iktp7q0-oArQvI6Gkg5Vd_5RNwO3sjrpDtpoO_NWxgVJ_RXBUcEROWA90qt14vdJRZVvpWrJ_kFVfMXXzhUW2vHtaeV2dHowGFJTGNP8zwnSDWeOokidggRoCodwDm6V8OBjQf1s5TF_z3FP0WHCbCbVWeo8blsoWNv8_VaCx1Fa4s3ZNfgW52jOQWla-yKcMwyHPvY1N0o5HHynoY05Ay7GQax8jhTBXOAU-axRMQpdrlwhzEPMwFNOMWjcAiJYiIChiM2cgWQOY6Ete2VXaAHnwkv0GHkH1s5fQTpbpbCsC5RczaflVcId_Nckl5hT43a0PosQcUxjFLmuSm7Nin716i9j9PNfvItOqlLtWOW2WmjZrX8Ke9gp67kvZLwH7TfjfE
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9jivNNp-LH1IDSt-LaZp17GNK16Vpt09LGMZ_G0hYUYRtbxX_fa9iHT3vKxyVHcvBLcrnLBaFHkRtaDgu_CmfXXCWmmKrC6AGuCMmqaCDFVH7nEzLTeyev4864hr43b2FknNBfGRwREJUB3ku5Xi92l1iO9K1cPYkvqJq_uLzvKGvtuPK00tuKM-jTOHIiW7HtvpcoLOnHktgmhIOqdABn7G4FBzoaVM9SFv_3FPcEHcbAblaeotrnsoka9ubrtSY6CtcWb8iuwbc6Q3MHlK6Rxf0RTXHkYl21Qp9F8UfiOz6j2EoxiJVFqSzoA5xQm8Y8SrDFuDWMmJ9yaMIcHPhDSCQT7lEc0sDiQGY45Ma2V3qOHlzKbU-FkU-2cpp4yW6WXDMuUH02nxWXCHeyTJBubk61ytD6LEDF0bRCZJkuOiYpeleotY_T9X7yPWp4PAwmgc_ebtBxRamctPR2C9XL5U9xC7t2Ke6ktP8AiuiQ5A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DERIVATIVES+OF+2-AMINOPYRIDINE+AS+ADENOSINE+A2B+RECEPTOR+ANTAGONISTS+AND+LIGANDS+OF+THE+MELATONIN+MT3+RECEPTORS&rft.inventor=Camacho+G%C3%B3mez%2C+Juan+Alberto&rft.inventor=Castro-Palomino+Laria%2C+Julio+Cesar&rft.inventor=Mendoza+Lizaldez%2C+Adela&rft.date=2020-03-20&rft.externalDBID=T1&rft.externalDocID=HRP20200044TT1